AABB Launches New COVID-19 Convalescent Plasma Website

    AABB recently launched a new website to share information with the public, blood collectors and clinicians about convalescent plasma from individuals who have recovered from COVID-19 (CCP). FDA recently announced new guidelines permitting the use of CCP as an investigational treatment for patients with moderate or severe COVID-19 infections. Many AABB-accredited blood centers are now collecting CCP. The website, COVIDPlasma.org, includes information to help identify eligible CCP donors and a tool to assist those donors in contacting their local blood center or hospital blood collector to schedule a CCP donation. In addition, the website provides CCP resources for blood collectors and the blood community.

    1 Like
    Recent Stories
    AABB Releases 2020 Billing Guide as Complimentary Benefit

    Big Data Is Focus of Latest Issue of AABB News

    FDA Issues EUA for COVID-19 Convalescent Plasma; AABB Toolkit Now Available